(Updated - August 19, 2026 5:30 AM EDT)

BMO Capital analyst David Lebowitz initiates coverage on Bicara Therapeutics Inc ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE